Future Oncology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=590648, encodeId=c34859064853, content=太慢了 1月7号投稿到现在毫无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e42d2481475, createdName=1245c133m02暂无昵称, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190033, encodeId=46772190033b4, content=投稿3个月，状态从In Peer Review 改为Under Consideration，请问这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Thu Feb 29 09:33:12 CST 2024, time=2024-02-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=968792, encodeId=a51e968e923a, content=请问有用快速通道和加快见刊的吗？一般需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad95447046, createdName=ms1000000289565013, createdTime=Thu May 27 00:27:46 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583923, encodeId=d329583923a0, content=1.9日submission,1.17under review,1.27under consideration 这是什么意思呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/10/04/9e57ad5ae2c68860f8676afb65c76ceb.jpg, createdBy=83f12053869, createdName=ivan_1999, createdTime=Tue Jan 28 00:00:00 CST 2020, time=2020-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189554, encodeId=290b118955478, content=审稿速度:6.0 偏重的研究方向：肿瘤生信实验 经验分享：20年12月投稿，21年6月返回，789月改了2次，10月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=467f5325567, createdName=148ba2a9m05暂无昵称, createdTime=Tue Feb 01 16:33:54 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565301, encodeId=54d356530127, content=2018年12月9日小修返修回去，至今仍未分配编辑(ADM:not assigned,under consideration)，不知是不是圣诞节的缘故，临近毕业等得好焦急！希望好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Tue Jan 08 00:00:00 CST 2019, time=2019-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061247, encodeId=4fcd106124ee0, content=请问外审要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sun Oct 17 16:23:41 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974339, encodeId=e2d19e43390c, content=这个杂志现在很慢了吗？一审45天，大修提交也已经40多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Thu Jun 17 10:58:23 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112771, encodeId=77502112e71ff, content=这个杂志接受综述吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35248523751, createdName=ms6000000603665223, createdTime=Thu Feb 02 17:46:47 CST 2023, time=2023-02-02, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2111295, encodeId=69f52111295b0, content=一个月分配编辑，三个月外审，大修后一周小修，小修后一个月接收，总共耗时五个月，审稿人和编辑都不错。现在想知道接收后后续什么流程？等待校稿Production system (PXE) 系统在哪里？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bab6538564, createdName=ms3000001908560299, createdTime=Tue Jan 24 12:00:09 CST 2023, time=2023-01-24, status=1, ipAttribution=黑龙江省)]

2020-05-11 1245c133m02暂无昵称

太慢了 1月7号投稿到现在毫无音讯

193 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=590648, encodeId=c34859064853, content=太慢了 1月7号投稿到现在毫无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e42d2481475, createdName=1245c133m02暂无昵称, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190033, encodeId=46772190033b4, content=投稿3个月，状态从In Peer Review 改为Under Consideration，请问这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Thu Feb 29 09:33:12 CST 2024, time=2024-02-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=968792, encodeId=a51e968e923a, content=请问有用快速通道和加快见刊的吗？一般需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad95447046, createdName=ms1000000289565013, createdTime=Thu May 27 00:27:46 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583923, encodeId=d329583923a0, content=1.9日submission,1.17under review,1.27under consideration 这是什么意思呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/10/04/9e57ad5ae2c68860f8676afb65c76ceb.jpg, createdBy=83f12053869, createdName=ivan_1999, createdTime=Tue Jan 28 00:00:00 CST 2020, time=2020-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189554, encodeId=290b118955478, content=审稿速度:6.0 偏重的研究方向：肿瘤生信实验 经验分享：20年12月投稿，21年6月返回，789月改了2次，10月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=467f5325567, createdName=148ba2a9m05暂无昵称, createdTime=Tue Feb 01 16:33:54 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565301, encodeId=54d356530127, content=2018年12月9日小修返修回去，至今仍未分配编辑(ADM:not assigned,under consideration)，不知是不是圣诞节的缘故，临近毕业等得好焦急！希望好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Tue Jan 08 00:00:00 CST 2019, time=2019-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061247, encodeId=4fcd106124ee0, content=请问外审要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sun Oct 17 16:23:41 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974339, encodeId=e2d19e43390c, content=这个杂志现在很慢了吗？一审45天，大修提交也已经40多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Thu Jun 17 10:58:23 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112771, encodeId=77502112e71ff, content=这个杂志接受综述吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35248523751, createdName=ms6000000603665223, createdTime=Thu Feb 02 17:46:47 CST 2023, time=2023-02-02, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2111295, encodeId=69f52111295b0, content=一个月分配编辑，三个月外审，大修后一周小修，小修后一个月接收，总共耗时五个月，审稿人和编辑都不错。现在想知道接收后后续什么流程？等待校稿Production system (PXE) 系统在哪里？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bab6538564, createdName=ms3000001908560299, createdTime=Tue Jan 24 12:00:09 CST 2023, time=2023-01-24, status=1, ipAttribution=黑龙江省)]

2024-02-29 重复的用户名来自浙江省

投稿3个月，状态从In Peer Review 改为Under Consideration，请问这是什么意思？

21 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=590648, encodeId=c34859064853, content=太慢了 1月7号投稿到现在毫无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e42d2481475, createdName=1245c133m02暂无昵称, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190033, encodeId=46772190033b4, content=投稿3个月，状态从In Peer Review 改为Under Consideration，请问这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Thu Feb 29 09:33:12 CST 2024, time=2024-02-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=968792, encodeId=a51e968e923a, content=请问有用快速通道和加快见刊的吗？一般需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad95447046, createdName=ms1000000289565013, createdTime=Thu May 27 00:27:46 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583923, encodeId=d329583923a0, content=1.9日submission,1.17under review,1.27under consideration 这是什么意思呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/10/04/9e57ad5ae2c68860f8676afb65c76ceb.jpg, createdBy=83f12053869, createdName=ivan_1999, createdTime=Tue Jan 28 00:00:00 CST 2020, time=2020-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189554, encodeId=290b118955478, content=审稿速度:6.0 偏重的研究方向：肿瘤生信实验 经验分享：20年12月投稿，21年6月返回，789月改了2次，10月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=467f5325567, createdName=148ba2a9m05暂无昵称, createdTime=Tue Feb 01 16:33:54 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565301, encodeId=54d356530127, content=2018年12月9日小修返修回去，至今仍未分配编辑(ADM:not assigned,under consideration)，不知是不是圣诞节的缘故，临近毕业等得好焦急！希望好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Tue Jan 08 00:00:00 CST 2019, time=2019-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061247, encodeId=4fcd106124ee0, content=请问外审要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sun Oct 17 16:23:41 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974339, encodeId=e2d19e43390c, content=这个杂志现在很慢了吗？一审45天，大修提交也已经40多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Thu Jun 17 10:58:23 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112771, encodeId=77502112e71ff, content=这个杂志接受综述吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35248523751, createdName=ms6000000603665223, createdTime=Thu Feb 02 17:46:47 CST 2023, time=2023-02-02, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2111295, encodeId=69f52111295b0, content=一个月分配编辑，三个月外审，大修后一周小修，小修后一个月接收，总共耗时五个月，审稿人和编辑都不错。现在想知道接收后后续什么流程？等待校稿Production system (PXE) 系统在哪里？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bab6538564, createdName=ms3000001908560299, createdTime=Tue Jan 24 12:00:09 CST 2023, time=2023-01-24, status=1, ipAttribution=黑龙江省)]

2021-05-27 ms1000000289565013

请问有用快速通道和加快见刊的吗？一般需要多久

53 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=590648, encodeId=c34859064853, content=太慢了 1月7号投稿到现在毫无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e42d2481475, createdName=1245c133m02暂无昵称, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190033, encodeId=46772190033b4, content=投稿3个月，状态从In Peer Review 改为Under Consideration，请问这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Thu Feb 29 09:33:12 CST 2024, time=2024-02-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=968792, encodeId=a51e968e923a, content=请问有用快速通道和加快见刊的吗？一般需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad95447046, createdName=ms1000000289565013, createdTime=Thu May 27 00:27:46 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583923, encodeId=d329583923a0, content=1.9日submission,1.17under review,1.27under consideration 这是什么意思呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/10/04/9e57ad5ae2c68860f8676afb65c76ceb.jpg, createdBy=83f12053869, createdName=ivan_1999, createdTime=Tue Jan 28 00:00:00 CST 2020, time=2020-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189554, encodeId=290b118955478, content=审稿速度:6.0 偏重的研究方向：肿瘤生信实验 经验分享：20年12月投稿，21年6月返回，789月改了2次，10月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=467f5325567, createdName=148ba2a9m05暂无昵称, createdTime=Tue Feb 01 16:33:54 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565301, encodeId=54d356530127, content=2018年12月9日小修返修回去，至今仍未分配编辑(ADM:not assigned,under consideration)，不知是不是圣诞节的缘故，临近毕业等得好焦急！希望好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Tue Jan 08 00:00:00 CST 2019, time=2019-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061247, encodeId=4fcd106124ee0, content=请问外审要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sun Oct 17 16:23:41 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974339, encodeId=e2d19e43390c, content=这个杂志现在很慢了吗？一审45天，大修提交也已经40多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Thu Jun 17 10:58:23 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112771, encodeId=77502112e71ff, content=这个杂志接受综述吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35248523751, createdName=ms6000000603665223, createdTime=Thu Feb 02 17:46:47 CST 2023, time=2023-02-02, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2111295, encodeId=69f52111295b0, content=一个月分配编辑，三个月外审，大修后一周小修，小修后一个月接收，总共耗时五个月，审稿人和编辑都不错。现在想知道接收后后续什么流程？等待校稿Production system (PXE) 系统在哪里？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bab6538564, createdName=ms3000001908560299, createdTime=Tue Jan 24 12:00:09 CST 2023, time=2023-01-24, status=1, ipAttribution=黑龙江省)]

2020-01-28 ivan_1999

1.9日submission,1.17under review,1.27under consideration 这是什么意思呀

112 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=590648, encodeId=c34859064853, content=太慢了 1月7号投稿到现在毫无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e42d2481475, createdName=1245c133m02暂无昵称, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190033, encodeId=46772190033b4, content=投稿3个月，状态从In Peer Review 改为Under Consideration，请问这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Thu Feb 29 09:33:12 CST 2024, time=2024-02-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=968792, encodeId=a51e968e923a, content=请问有用快速通道和加快见刊的吗？一般需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad95447046, createdName=ms1000000289565013, createdTime=Thu May 27 00:27:46 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583923, encodeId=d329583923a0, content=1.9日submission,1.17under review,1.27under consideration 这是什么意思呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/10/04/9e57ad5ae2c68860f8676afb65c76ceb.jpg, createdBy=83f12053869, createdName=ivan_1999, createdTime=Tue Jan 28 00:00:00 CST 2020, time=2020-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189554, encodeId=290b118955478, content=审稿速度:6.0 偏重的研究方向：肿瘤生信实验 经验分享：20年12月投稿，21年6月返回，789月改了2次，10月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=467f5325567, createdName=148ba2a9m05暂无昵称, createdTime=Tue Feb 01 16:33:54 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565301, encodeId=54d356530127, content=2018年12月9日小修返修回去，至今仍未分配编辑(ADM:not assigned,under consideration)，不知是不是圣诞节的缘故，临近毕业等得好焦急！希望好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Tue Jan 08 00:00:00 CST 2019, time=2019-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061247, encodeId=4fcd106124ee0, content=请问外审要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sun Oct 17 16:23:41 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974339, encodeId=e2d19e43390c, content=这个杂志现在很慢了吗？一审45天，大修提交也已经40多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Thu Jun 17 10:58:23 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112771, encodeId=77502112e71ff, content=这个杂志接受综述吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35248523751, createdName=ms6000000603665223, createdTime=Thu Feb 02 17:46:47 CST 2023, time=2023-02-02, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2111295, encodeId=69f52111295b0, content=一个月分配编辑，三个月外审，大修后一周小修，小修后一个月接收，总共耗时五个月，审稿人和编辑都不错。现在想知道接收后后续什么流程？等待校稿Production system (PXE) 系统在哪里？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bab6538564, createdName=ms3000001908560299, createdTime=Tue Jan 24 12:00:09 CST 2023, time=2023-01-24, status=1, ipAttribution=黑龙江省)]

2022-02-01 148ba2a9m05暂无昵称

审稿速度:6.0
偏重的研究方向：肿瘤生信实验
经验分享：20年12月投稿，21年6月返回，789月改了2次，10月接受

54 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=590648, encodeId=c34859064853, content=太慢了 1月7号投稿到现在毫无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e42d2481475, createdName=1245c133m02暂无昵称, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190033, encodeId=46772190033b4, content=投稿3个月，状态从In Peer Review 改为Under Consideration，请问这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Thu Feb 29 09:33:12 CST 2024, time=2024-02-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=968792, encodeId=a51e968e923a, content=请问有用快速通道和加快见刊的吗？一般需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad95447046, createdName=ms1000000289565013, createdTime=Thu May 27 00:27:46 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583923, encodeId=d329583923a0, content=1.9日submission,1.17under review,1.27under consideration 这是什么意思呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/10/04/9e57ad5ae2c68860f8676afb65c76ceb.jpg, createdBy=83f12053869, createdName=ivan_1999, createdTime=Tue Jan 28 00:00:00 CST 2020, time=2020-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189554, encodeId=290b118955478, content=审稿速度:6.0 偏重的研究方向：肿瘤生信实验 经验分享：20年12月投稿，21年6月返回，789月改了2次，10月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=467f5325567, createdName=148ba2a9m05暂无昵称, createdTime=Tue Feb 01 16:33:54 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565301, encodeId=54d356530127, content=2018年12月9日小修返修回去，至今仍未分配编辑(ADM:not assigned,under consideration)，不知是不是圣诞节的缘故，临近毕业等得好焦急！希望好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Tue Jan 08 00:00:00 CST 2019, time=2019-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061247, encodeId=4fcd106124ee0, content=请问外审要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sun Oct 17 16:23:41 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974339, encodeId=e2d19e43390c, content=这个杂志现在很慢了吗？一审45天，大修提交也已经40多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Thu Jun 17 10:58:23 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112771, encodeId=77502112e71ff, content=这个杂志接受综述吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35248523751, createdName=ms6000000603665223, createdTime=Thu Feb 02 17:46:47 CST 2023, time=2023-02-02, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2111295, encodeId=69f52111295b0, content=一个月分配编辑，三个月外审，大修后一周小修，小修后一个月接收，总共耗时五个月，审稿人和编辑都不错。现在想知道接收后后续什么流程？等待校稿Production system (PXE) 系统在哪里？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bab6538564, createdName=ms3000001908560299, createdTime=Tue Jan 24 12:00:09 CST 2023, time=2023-01-24, status=1, ipAttribution=黑龙江省)]

2019-01-08 1e235a1cm31(暂无匿称)

2018年12月9日小修返修回去，至今仍未分配编辑(ADM:not assigned,under consideration)，不知是不是圣诞节的缘故，临近毕业等得好焦急！希望好运！

163 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=590648, encodeId=c34859064853, content=太慢了 1月7号投稿到现在毫无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e42d2481475, createdName=1245c133m02暂无昵称, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190033, encodeId=46772190033b4, content=投稿3个月，状态从In Peer Review 改为Under Consideration，请问这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Thu Feb 29 09:33:12 CST 2024, time=2024-02-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=968792, encodeId=a51e968e923a, content=请问有用快速通道和加快见刊的吗？一般需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad95447046, createdName=ms1000000289565013, createdTime=Thu May 27 00:27:46 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583923, encodeId=d329583923a0, content=1.9日submission,1.17under review,1.27under consideration 这是什么意思呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/10/04/9e57ad5ae2c68860f8676afb65c76ceb.jpg, createdBy=83f12053869, createdName=ivan_1999, createdTime=Tue Jan 28 00:00:00 CST 2020, time=2020-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189554, encodeId=290b118955478, content=审稿速度:6.0 偏重的研究方向：肿瘤生信实验 经验分享：20年12月投稿，21年6月返回，789月改了2次，10月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=467f5325567, createdName=148ba2a9m05暂无昵称, createdTime=Tue Feb 01 16:33:54 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565301, encodeId=54d356530127, content=2018年12月9日小修返修回去，至今仍未分配编辑(ADM:not assigned,under consideration)，不知是不是圣诞节的缘故，临近毕业等得好焦急！希望好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Tue Jan 08 00:00:00 CST 2019, time=2019-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061247, encodeId=4fcd106124ee0, content=请问外审要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sun Oct 17 16:23:41 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974339, encodeId=e2d19e43390c, content=这个杂志现在很慢了吗？一审45天，大修提交也已经40多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Thu Jun 17 10:58:23 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112771, encodeId=77502112e71ff, content=这个杂志接受综述吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35248523751, createdName=ms6000000603665223, createdTime=Thu Feb 02 17:46:47 CST 2023, time=2023-02-02, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2111295, encodeId=69f52111295b0, content=一个月分配编辑，三个月外审，大修后一周小修，小修后一个月接收，总共耗时五个月，审稿人和编辑都不错。现在想知道接收后后续什么流程？等待校稿Production system (PXE) 系统在哪里？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bab6538564, createdName=ms3000001908560299, createdTime=Tue Jan 24 12:00:09 CST 2023, time=2023-01-24, status=1, ipAttribution=黑龙江省)]

2021-10-17 凶巴巴恰北北怪兽

请问外审要多久呀

50 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=590648, encodeId=c34859064853, content=太慢了 1月7号投稿到现在毫无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e42d2481475, createdName=1245c133m02暂无昵称, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190033, encodeId=46772190033b4, content=投稿3个月，状态从In Peer Review 改为Under Consideration，请问这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Thu Feb 29 09:33:12 CST 2024, time=2024-02-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=968792, encodeId=a51e968e923a, content=请问有用快速通道和加快见刊的吗？一般需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad95447046, createdName=ms1000000289565013, createdTime=Thu May 27 00:27:46 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583923, encodeId=d329583923a0, content=1.9日submission,1.17under review,1.27under consideration 这是什么意思呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/10/04/9e57ad5ae2c68860f8676afb65c76ceb.jpg, createdBy=83f12053869, createdName=ivan_1999, createdTime=Tue Jan 28 00:00:00 CST 2020, time=2020-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189554, encodeId=290b118955478, content=审稿速度:6.0 偏重的研究方向：肿瘤生信实验 经验分享：20年12月投稿，21年6月返回，789月改了2次，10月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=467f5325567, createdName=148ba2a9m05暂无昵称, createdTime=Tue Feb 01 16:33:54 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565301, encodeId=54d356530127, content=2018年12月9日小修返修回去，至今仍未分配编辑(ADM:not assigned,under consideration)，不知是不是圣诞节的缘故，临近毕业等得好焦急！希望好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Tue Jan 08 00:00:00 CST 2019, time=2019-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061247, encodeId=4fcd106124ee0, content=请问外审要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sun Oct 17 16:23:41 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974339, encodeId=e2d19e43390c, content=这个杂志现在很慢了吗？一审45天，大修提交也已经40多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Thu Jun 17 10:58:23 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112771, encodeId=77502112e71ff, content=这个杂志接受综述吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35248523751, createdName=ms6000000603665223, createdTime=Thu Feb 02 17:46:47 CST 2023, time=2023-02-02, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2111295, encodeId=69f52111295b0, content=一个月分配编辑，三个月外审，大修后一周小修，小修后一个月接收，总共耗时五个月，审稿人和编辑都不错。现在想知道接收后后续什么流程？等待校稿Production system (PXE) 系统在哪里？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bab6538564, createdName=ms3000001908560299, createdTime=Tue Jan 24 12:00:09 CST 2023, time=2023-01-24, status=1, ipAttribution=黑龙江省)]

2021-06-17 prima

这个杂志现在很慢了吗？一审45天，大修提交也已经40多天了

51 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=590648, encodeId=c34859064853, content=太慢了 1月7号投稿到现在毫无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e42d2481475, createdName=1245c133m02暂无昵称, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190033, encodeId=46772190033b4, content=投稿3个月，状态从In Peer Review 改为Under Consideration，请问这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Thu Feb 29 09:33:12 CST 2024, time=2024-02-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=968792, encodeId=a51e968e923a, content=请问有用快速通道和加快见刊的吗？一般需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad95447046, createdName=ms1000000289565013, createdTime=Thu May 27 00:27:46 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583923, encodeId=d329583923a0, content=1.9日submission,1.17under review,1.27under consideration 这是什么意思呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/10/04/9e57ad5ae2c68860f8676afb65c76ceb.jpg, createdBy=83f12053869, createdName=ivan_1999, createdTime=Tue Jan 28 00:00:00 CST 2020, time=2020-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189554, encodeId=290b118955478, content=审稿速度:6.0 偏重的研究方向：肿瘤生信实验 经验分享：20年12月投稿，21年6月返回，789月改了2次，10月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=467f5325567, createdName=148ba2a9m05暂无昵称, createdTime=Tue Feb 01 16:33:54 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565301, encodeId=54d356530127, content=2018年12月9日小修返修回去，至今仍未分配编辑(ADM:not assigned,under consideration)，不知是不是圣诞节的缘故，临近毕业等得好焦急！希望好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Tue Jan 08 00:00:00 CST 2019, time=2019-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061247, encodeId=4fcd106124ee0, content=请问外审要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sun Oct 17 16:23:41 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974339, encodeId=e2d19e43390c, content=这个杂志现在很慢了吗？一审45天，大修提交也已经40多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Thu Jun 17 10:58:23 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112771, encodeId=77502112e71ff, content=这个杂志接受综述吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35248523751, createdName=ms6000000603665223, createdTime=Thu Feb 02 17:46:47 CST 2023, time=2023-02-02, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2111295, encodeId=69f52111295b0, content=一个月分配编辑，三个月外审，大修后一周小修，小修后一个月接收，总共耗时五个月，审稿人和编辑都不错。现在想知道接收后后续什么流程？等待校稿Production system (PXE) 系统在哪里？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bab6538564, createdName=ms3000001908560299, createdTime=Tue Jan 24 12:00:09 CST 2023, time=2023-01-24, status=1, ipAttribution=黑龙江省)]

2023-02-02 ms6000000603665223 来自湖南省

这个杂志接受综述吗

45 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=590648, encodeId=c34859064853, content=太慢了 1月7号投稿到现在毫无音讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e42d2481475, createdName=1245c133m02暂无昵称, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2190033, encodeId=46772190033b4, content=投稿3个月，状态从In Peer Review 改为Under Consideration，请问这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ef5508120, createdName=重复的用户名, createdTime=Thu Feb 29 09:33:12 CST 2024, time=2024-02-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=968792, encodeId=a51e968e923a, content=请问有用快速通道和加快见刊的吗？一般需要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad95447046, createdName=ms1000000289565013, createdTime=Thu May 27 00:27:46 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583923, encodeId=d329583923a0, content=1.9日submission,1.17under review,1.27under consideration 这是什么意思呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/10/04/9e57ad5ae2c68860f8676afb65c76ceb.jpg, createdBy=83f12053869, createdName=ivan_1999, createdTime=Tue Jan 28 00:00:00 CST 2020, time=2020-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189554, encodeId=290b118955478, content=审稿速度:6.0 偏重的研究方向：肿瘤生信实验 经验分享：20年12月投稿，21年6月返回，789月改了2次，10月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=467f5325567, createdName=148ba2a9m05暂无昵称, createdTime=Tue Feb 01 16:33:54 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565301, encodeId=54d356530127, content=2018年12月9日小修返修回去，至今仍未分配编辑(ADM:not assigned,under consideration)，不知是不是圣诞节的缘故，临近毕业等得好焦急！希望好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Tue Jan 08 00:00:00 CST 2019, time=2019-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061247, encodeId=4fcd106124ee0, content=请问外审要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Sun Oct 17 16:23:41 CST 2021, time=2021-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974339, encodeId=e2d19e43390c, content=这个杂志现在很慢了吗？一审45天，大修提交也已经40多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Thu Jun 17 10:58:23 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112771, encodeId=77502112e71ff, content=这个杂志接受综述吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35248523751, createdName=ms6000000603665223, createdTime=Thu Feb 02 17:46:47 CST 2023, time=2023-02-02, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2111295, encodeId=69f52111295b0, content=一个月分配编辑，三个月外审，大修后一周小修，小修后一个月接收，总共耗时五个月，审稿人和编辑都不错。现在想知道接收后后续什么流程？等待校稿Production system (PXE) 系统在哪里？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bab6538564, createdName=ms3000001908560299, createdTime=Tue Jan 24 12:00:09 CST 2023, time=2023-01-24, status=1, ipAttribution=黑龙江省)]

2023-01-24 ms3000001908560299 来自黑龙江省

一个月分配编辑，三个月外审，大修后一周小修，小修后一个月接收，总共耗时五个月，审稿人和编辑都不错。现在想知道接收后后续什么流程？等待校稿Production system (PXE) 系统在哪里？

38 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务